Physician profile
Manpreet Singh
NPI 1205491073
$319.22
in general payments reported to CMS, 2019-2025
8 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2024: $22.91 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2021 | |
| Mannkind Corporation | $60.75 | 2025 | |
| Chiesi USA, INC. | $30.00 | 2025 | Mycapssa |
| Tolmar, INC. | $26.54 | 2025 | Jatenzo |
| Lilly USA, LLC | $22.91 | 2024 | |
| Intra-Sana Laboratories | $22.05 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| E.R. Squibb & Sons, L.L.C. | $16.09 | 2025 | Sotyktu |
| Cipher Pharmaceuticals US LLC | $15.88 | 2025 | Natroba, Spinosad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manpreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.